Abstract:Background: Pericytes are crucial for the development, stabilization, and functional regulation of microvasculature, especially in the retina. In diabetic retinopathy (DR), early loss of pericytes is a key event that drives microvascular dysfunction. Despite their critical role, the mechanisms underlying the functional heterogeneity of pericytes in DR remain poorly understood, impeding the development of effective therapeutic strategies. Methods: We employed single-cell RNA sequencing to construct a comprehensive single-cell atlas of non-diabetic and diabetic retinas. Using bioinformatic clustering and subcluster analysis, we identified a specific pericyte subcluster associated with diabetic microvascular complications. Differential gene expression analysis and immunofluorescence validation highlighted PTTG1 as a potential key regulator of pericyte dysfunction. To investigate its functional role, we emplyed CRISPR/Cas9 and adenoviral vectors to modulate PTTG1 expression in vitro and in vivo. Combined transcriptomic and metabolomic approaches were used to explore the mechanistic pathways through which PTTG1 influences pericyte biology and vascular function. Results: We identified a novel pericyte subcluster characterized by elevated expression of PTTG1, which was strongly correlated with diabetic microvascular dysfunction. Silencing PTTG1 using CRISPR/Cas9 and siRNA in vitro mitigated pericyte dysfunction under high-glucose conditions. Targeted knockdown of PTTG1 using viral vectors improved retinal vascular integrity and reduced neovascularization in diabetic mice. Transcriptomic and untargeted metabolomic analyses revealed that PTTG1 knockdown reprogrammed pericyte energy metabolism by modulating glycolysis pathway genes, reducing oxidative stress, and restoring pericyte function, ultimately alleviating microvascular dysfunction in DR. Conclusions: PTTG1 plays a critical role in regulating pericyte dysfunction and maintaining vascular homeostasis in diabetic retinopathy. By modulating key metabolic pathways and pericyte phenotypes, PTTG1 represents a promising therapeutic target for treating diabetic microvascular complications. These insights offer a novel molecular framework for developing targeted therapies aimed at restoring retinal vascular health in diabetic patients.

PTTG1-Mediated Pericyte Dysfunction Drives Diabetes-Induced Microvascular Dysfunction

Role of Pericytes in Mechanisms of Diabetic Retinopathy

Targeting Pericyte-Expressed Circ_0001186 for the Inhibition of Diabetes-Induced Retinal Vascular Dysfunction

The Effects of Pleiotrophin in Proliferative Diabetic Retinopathy

Pathogenic Role of Diabetes-Induced PPAR-α Down-Regulation in Microvascular Dysfunction.

Targeting Pericyte–endothelial Cell Crosstalk by Circular RNA-cPWWP2A Inhibition Aggravates Diabetes-Induced Microvascular Dysfunction

TPTEP1 suppresses high glucose-induced dysfunction in retinal vascular endothelial cells by interacting with STAT3 and targeting VEGFA

Inhibition of Drp1 ameliorates diabetic retinopathy by regulating mitochondrial homeostasis

LncRNA TDRG1-Mediated Overexpression of VEGF Aggravated Retinal Microvascular Endothelial Cell Dysfunction in Diabetic Retinopathy

Prostaglandin F2α protects against pericyte apoptosis by inhibiting the PI3K/Akt/GSK3β/β-catenin signaling pathway

Drp1-dependent mitochondrial fragmentation mediates photoreceptor abnormalities in type 1 diabetic retina

TGR5 Activation Ameliorates Mitochondrial Homeostasis via Regulating the PKCδ/Drp1-HK2 Signaling in Diabetic Retinopathy

Transthyretin-induced increase in circ_0007411 represses neovascularization of human retinal microvascular endothelial cells in hyperglycemia via the miR-548m/PTPN12/SKP1/EGFR pathway

METTL3-mediated <i>N</i><SUP>6</SUP>-methyladenosine modification governs pericyte dysfunction during diabetes-induced retinal vascular complication

Peroxisome proliferator-activated receptor α protects capillary pericytes in the retina.

Diabetes Promotes Retinal Vascular Endothelial Cell Injury by Inducing CCN1 Expression

PPP1CA/YAP/GS/Gln/mTORC1 pathway activates retinal Muller cells during diabetic retinopathy

Single-cell RNA sequencing reveals a unique pericyte type associated with capillary dysfunction

The Protective Role of Apelin in the Early Stages of Diabetic Retinopathy

Knockdown of lncRNA TUG1 alleviates diabetic retinal vascular dysfunction through regulating miR-524-5p/FGFR2

Overexpressed Poldip2 Incurs Retinal Fibrosis via the TGF-β1/SMAD3 Signaling Pathway in Diabetic Retinopathy